6-K
Alterity Therapeutics Ltd (ATHE)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-163
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2026
Alterity Therapeutics Limited
(Name of Registrant)
Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)
ALTERITY THERAPEUTICS LIMITED
(a development stage enterprise)
The following exhibits are submitted:
| 99.1 | Initial Director's Interest Notice - Cunningham |
|---|
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Alterity Therapeutics Limited | |
|---|---|
| By: | /s/ Julian Babarczy |
| Julian Babarczy | |
| Chairman |
Date: April 21, 2026
2
ex_948344.htm
Exhibit 99.1
Appendix 3XInitial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
| Name of entity Alterity Therapeutics Limited |
|---|
| ABN 37 080 699 065 |
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Ann Cunningham |
|---|---|
| Date of appointment | 17 April 2026 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Number & class of securities<br><br> <br><br><br> <br>Nil. |
|---|
- See chapter 19 for defined terms.
11/3/2002
Appendix 3X Page 1
Appendix 3XInitial Director’s Interest Notice
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interest<br><br> <br>Note: Provide details of the circumstances giving rise to the relevant interest.<br><br> <br><br><br> <br><br><br> <br><br><br> <br><br><br> <br>N/A | Number & class of Securities<br><br> <br><br><br> <br><br><br> <br><br><br> <br><br><br> <br><br><br> <br><br><br> <br>Nil |
|---|
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder<br><br> <br>(if issued securities) | N/A |
| No. and class of securities to which interest relates | N/A |
- See chapter 19 for defined terms.
| Appendix 3X Page 2 | 11/3/2002 |
|---|